PIK3CA and cancer: Thus, to study dose-dependent effects of pathological PI3K hyperactivation in a developmental system of relevance to cancer and PROS, we engineered isogenic human induced pluripotent stem cells (iPSCs) to express PIK3CAH1047R from one or both endogenous loci.